Skip to main content
main-content

Coronavirus Update

Weitere Open Access Artikel aus unseren Journals

01.12.2020 | COVID-19 | Research | Ausgabe 1/2020 Open Access

Inflammatory phenotyping predicts clinical outcome in COVID-19

Coronavirus disease 2019 (COVID-19) has been confirmed in 21,294,845 people worldwide as of 16th August 2020, carrying a mortality of nearly 4%, compared with a mortality rate of less than 1% from influenza [ 1 ]. Although this mortality rate maybe …

Autoren:
H. Burke, A. Freeman, D. C. Cellura, B. L. Stuart, N. J. Brendish, S. Poole, F. Borca, H. T. T. Phan, N. Sheard, S. Williams, C. M. Spalluto, K. J. Staples, T. W. Clark, T. M. A. Wilkinson, on behalf of the REACT COVID investigators

01.12.2020 | COVID-19 | Review | Ausgabe 1/2020 Open Access

The prognosis and prevention measures for mental health in COVID-19 patients: through the experience of SARS

Due to the high pathogenicity and mortality, the COVID-19 disaster caused global panic and anxiety. At present, diagnosis and treatment are of great concern. As time progresses, however, the sequelae caused by many other organ system complications …

Autoren:
Guo Heng Mo, Zi Xuan Wang, Xiao Si Chen, Qunguang Jiang

01.12.2020 | COVID-19 | Commentary | Ausgabe 1/2020 Open Access

Conflict and COVID-19: a double burden for Afghanistan’s healthcare system

The novel coronavirus disease (COVID-19) has put an additional strain on Afghanistan’s weak healthcare system. Prior to the pandemic, the government and its allies had already problems in providing high quality health services for the people in …

Autoren:
Don Eliseo Lucero-Prisno III, Mohammad Yasir Essar, Attaullah Ahmadi, Xu Lin, Yusuff Adebayo Adebisi

01.12.2020 | COVID-19 | Research article | Ausgabe 1/2020 Open Access

Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series

The novel coronavirus diseases 2019(COVID-19) first reported in Wuhan, Hubei province, China [ 1 , 2 ]. It then spread widely in China and other nations around the world [ 3 , 4 ]. With the COVID-19 global pandemic, more and more cases of death …

Autoren:
Tao Yao, Yan Gao, Qin Cui, Bo Peng, Yan Chen, Jiansheng Li, Chao Huang, Chunping He, Jie Pu, Jiajun Wei, Yanqiang Zhan, Jie Yan, Jinghua Tian, Zhaohui Zhang, Zhichao Liu

01.12.2020 | COVID-19 | Short Communications | Ausgabe 1/2020 Open Access

COVID-19: the androgen hypothesis

Autoren:
Jeff John, Ken Kesner

01.12.2020 | COVID-19 | Case report | Ausgabe 1/2020 Open Access

COVID-19 confirmed patients with negative antibodies results

During the outbreak of coronavirus 2019 (COVID-19) [ 1 – 3 ], a small proportion of confirmed COVID-19 patients fail to produce IgM or IgG antibodies against SARS-CoV-2 even 40 days or longer periods of time after onset of their initial symptoms.

Autoren:
Jian Wang, Chong Chen, Qilin Li, Pengcheng Cai, Zheng Wang, Lin Wang

01.12.2020 | COVID-19 | Research Letter | Ausgabe 1/2020 Open Access

Rapid positioning of nasogastric tube by ultrasound in COVID-19 patients

Autoren:
Anyu Qian, Shanxiang Xu, Xiao Lu, Luping Tang, Mao Zhang, Xiao Chen

01.12.2020 | COVID-19 | Original research | Ausgabe 1/2020 Open Access

Pre-hospital care & interfacility transport of 385 COVID-19 emergency patients: an air ambulance perspective

COVID-19, the pandemic caused by the severe acute respiratory syndrome (SARS) coronavirus-2 (SARS-CoV-2), is challenging healthcare systems worldwide. In some countries, the number of serious cases has exceeded the resources available and the …

Autoren:
Peter Hilbert-Carius, Jörg Braun, Fikri Abu-Zidan, Jörn Adler, Jürgen Knapp, Didier Dandrifosse, Désirée Braun, Urs Pietsch, Patrick Adamczuk, Leif Rognås, Roland Albrecht

01.12.2020 | COVID-19 | Research | Ausgabe 1/2020 Open Access

Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in 2019, spread to most of the countries around the world, and the corona virus disease 2019 (COVID-19) has progressed into a global pandemic. Globally, as of …

Autoren:
Jie Li, Junwei Wang, Yi Yang, Peishan Cai, Jingchao Cao, Xuefeng Cai, Yu Zhang

01.12.2020 | COVID-19 | Research | Ausgabe 1/2020 Open Access

A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit

In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered in Wuhan City, China and rapidly developed into a pandemic that poses a serious threat to health care systems worldwide [ 1 – 3 ]. It soon became apparent …

Autoren:
Stefanie Kampmeier, Hauke Tönnies, Carlos L. Correa-Martinez, Alexander Mellmann, Vera Schwierzeck

01.12.2020 | COVID-19 | Research | Ausgabe 1/2020 Open Access

Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study

Optimal management of thrombotic complications that are recognised as a common feature of coronavirus disease 2019 (COVID-19) remains a major clinical challenge in intensive care units (ICUs) [ 1 – 3 ]. Proposed underlying mechanisms include an …

Autoren:
Akshay Shah, Killian Donovan, Anna McHugh, Manish Pandey, Louise Aaron, Charlotte A. Bradbury, Simon J. Stanworth, Raza Alikhan, Stephen Von Kier, Keith Maher, Nicola Curry, Susan Shapiro, Matthew J. Rowland, Matt Thomas, Richard Mason, Matthew Holland, Tom Holmes, Michael Ware, Stefan Gurney, Stuart R. McKechnie

01.12.2020 | COVID-19 | Letter | Ausgabe 1/2020 Open Access

A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

Autoren:
Farhan Raza Khan, Syed Murtaza Raza Kazmi, Najeeha Talat Iqbal, Junaid Iqbal, Syed Tariq Ali, Syed Akbar Abbas

01.12.2020 | COVID-19 | Commentary | Ausgabe 1/2020 Open Access

It is unprecedented: trial management during the COVID-19 pandemic and beyond

The COVID-19 pandemic has presented unique challenges for the clinical trial community, both in the rapid establishment of COVID-19 clinical trials and many existing non-COVID-19 studies either being temporarily paused (whether that is a complete …

Autoren:
Eleanor J. Mitchell, Khaled Ahmed, Suzanne Breeman, Seonaidh Cotton, Lynda Constable, Gillian Ferry, Kirsteen Goodman, Helen Hickey, Garry Meakin, Katy Mironov, Niamh Quann, Natalie Wakefield, Alison McDonald

01.12.2020 | COVID-19 | Letter | Ausgabe 1/2020 Open Access

Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial

Autoren:
Stefan Roehrig, Ali Ait Hssain, Nabil Al Hamid Shallik, Ingi Mohamed A. Elsaid, Salma Faisal Mustafa, Osama A. M. Smain, Ashraf Abdulla Molokhia, Marcus D. Lance

01.12.2020 | COVID-19 | Short report | Ausgabe 1/2020 Open Access

Characterization of codon usage pattern in SARS-CoV-2

The outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed significant threats to international health. The genetic traits as well as evolutionary processes in this novel …

Autor:
Wei Hou

01.12.2020 | COVID-19 | Research article | Ausgabe 1/2020 Open Access

Establishment of a pediatric COVID-19 biorepository: unique considerations and opportunities for studying the impact of the COVID-19 pandemic on children

The global pandemic of COVID-19, caused by the highly infectious and transmissible coronavirus, SARS-CoV-2, has become a leading cause of death in older adults [ 1 ]. While adults can develop life-threatening complications such as pneumonia, acute …

Autoren:
Rosiane Lima, Elizabeth F. Gootkind, Denis De la Flor, Laura J. Yockey, Evan A. Bordt, Paolo D’Avino, Shen Ning, Katerina Heath, Katherine Harding, Jaclyn Zois, Grace Park, Margot Hardcastle, Kathleen A. Grinke, Sheila Grimmel, Susan P. Davidson, Pamela J. Forde, Kathryn E. Hall, Anne M. Neilan, Juan D. Matute, Paul H. Lerou, Alessio Fasano, Jessica E. Shui, Andrea G. Edlow, Lael M. Yonker

01.12.2020 | COVID-19 | Research article | Ausgabe 1/2020 Open Access

Psychological correlates of COVID-19 pandemic in the Austrian population

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified first on January 10 in Wuhan, China. This virus triggers the COVID-19 pandemic, which was classified by the WHO on January 30, 2020, as a health emergency of international …

Autoren:
Claudia Traunmüller, Rene Stefitz, Kerstin Gaisbachgrabner, Andreas Schwerdtfeger

01.12.2020 | COVID-19 | Correction | Ausgabe 1/2020 Open Access

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

An amendment to this paper has been published and can be accessed via the original article.

Autoren:
Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, Alessandro Cuomo, Robin Emsley, Andrea Fagiolini, Giuseppe Imperadore, Taishiro Kishimoto, Giulia Michencigh, Michela Nosé, Marianna Purgato, Serdar Dursun, Brendon Stubbs, David Taylor, Graham Thornicroft, Philip B. Ward, Christoph Hiemke, Christoph U. Correll, Corrado Barbui

01.12.2020 | COVID-19 | Review | Ausgabe 1/2020 Open Access

Breastfeeding during the COVID-19 pandemic – a literature review for clinical practice

The COVID-19 pandemic is creating global disruption, causing markets to plummet and generating many questions in every area of life. Since it affects health in multiple ways, including sexual and reproductive health, publishing in all these areas …

Autoren:
Welma Lubbe, Elina Botha, Hannakaisa Niela-Vilen, Penny Reimers

01.12.2020 | COVID-19 | Case report | Ausgabe 1/2020 Open Access

Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience

Since the first case of novel coronavirus disease 2019 (COVID-19) was reported in Tokyo on January 24, 2020 [ 1 ], the number of cases has continued to rise [ 2 ]. “A state of emergency” was declared from April 7 to May 25, 2020. The total number …

Autoren:
Yuya Nogami, Yusuke Kobayashi, Kosuke Tsuji, Megumi Yokota, Hiroshi Nishio, Masaru Nakamura, Wataru Yamagami, Tohru Morisada, Eiichiro Tominaga, Kouji Banno, Daisuke Aoki

Webinare und Artikel zur Corona-Krise

Die aktuelle Entwicklung zu SARS-CoV-2 (2019-nCoV) und der Lungenkrankheit COVID-19 im Überblick. » zum Dossier

Bildnachweise